| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $23.91M | -50,000 | |
| CEO | 2.07M | $8.12M | - | |
| Dir | 1.48M | $5.78M | - | |
| CFO | 1.07M | $4.19M | - | |
| Other | 1.04M | $4.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2023 | Shafique Virani70 | Chief Business Officer | Sale+OE10b5-1 | 60,000 | $12.73 | $763,800.00 | -29.4% | -51.9% | -38.7% | |
| Jul 13, 2023 | Terry-Ann Burrell81 | Director | Sell | 117,000 | $12.07 | $1,412,413.53 | -68.1% | -45.2% | -32.8% | |
| Jul 12, 2023 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 56,818 | $12.54 | $712,242.04 | - | -41.5% | -36.4% | |
| Jul 11, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $6.89 | $61,193.66 | -0.1% | -0.3% | +6.6% | |
| Jun 29, 2023 | Tina Marriott Larson73 | President and COO | Sale+OE10b5-1 | 3,000 | $7.49 | $22,470.00 | -0.7% | +5.4% | +1.6% | |
| Jun 27, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $7.39 | $65,638.83 | -0.1% | +3.4% | +17.7% | |
| Jun 16, 2023 | Shafique Virani70 | Chief Business Officer | Sale+OE10b5-1 | 60,000 | $9.54 | $572,400.00 | -29.4% | -3.6% | +3.8% | |
| Jun 14, 2023 | Michael Secora74 | Chief Financial Officer | Sale+OE10b5-1 | 50,000 | $10.00 | $500,145.00 | -5.8% | -13.3% | -4.3% | |
| Jun 13, 2023 | Blake Borgeson68 | Director | Sell | 15,485 | $9.98 | $154,506.23 | -0.2% | -16.2% | -6.4% | |
| Jun 7, 2023 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 56,436 | $9.05 | $510,807.88 | -5.8% | -4.1% | -0.7% |